RxDoctor Payments Data

David Woodruff, MD

Family Medicine · Pandora, OHNPI 1154317188

Payments from drug & device makers

$10,373in general payments, 2019–2025

Across 736 payments — averaging $14.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$2K
  • AstraZeneca$828
  • Pfizer$641
  • Lilly USA, LLC$563
  • Amgen$505
  • plus $4K from 45 others

What the payments were for

  • Food & beverage$10,368100%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,373 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$124,027
Medicare patients
361
Services billed
1,546

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl33$124,486
EliquisApixaban162$99,551
JanuviaSitagliptin Phosphate31$34,452
AbrysvoRsv Vacc, Pref A And Pref B/Pf102$32,612
XareltoRivaroxaban68$25,640
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog78$18,424
TrulicityDulaglutide13$13,152
LinzessLinaclotide17$11,946
RexultiBrexpiprazole20$11,297
Atrovent HfaIpratropium Bromide23$11,209
MyrbetriqMirabegron47$9,504
Fiasp FlextouchInsulin Aspart (Niacinamide)20$7,415
Potassium Chloride259$7,236
InvokanaCanagliflozin12$7,062
Lantus SolostarInsulin Glargine,hum.Rec.Anlog49$6,960

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$641$132,163264 claims
MerckJanuvia$463$34,45231 claims
Johnson & JohnsonXarelto, Invokana$42$32,70280 claims
GSKBreo Ellipta, Shingrix, Arnuity Ellipta$83$13,36148 claims
Lilly USA, LLCTrulicity$563$13,15213 claims
AbbVieLinzess$1,732$11,94617 claims
Otsuka America Pharmaceutical, Inc.Rexulti$184$11,29720 claims
Astellas Pharma US IncMyrbetriq$143$9,50447 claims
AstraZenecaBrilinta$828$5,83637 claims
Boehringer IngelheimJardiance$478$4,57622 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Pandora

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →